PETER P. PFREUNDSCHUH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER P. PFREUNDSCHUH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER P. PFREUNDSCHUH. PETER P. PFREUNDSCHUH is Chief Financial Officer in IMMUNOMEDICS INC ($IMMU) and CFO in Sucampo Pharmaceuticals, Inc. ($SCMP) and Chief Financial Officer in UroGen Pharma Ltd. ($URGN) and Chief Financial Officer in Frequency Therapeutics, Inc. ($FREQ).
Latest Insider Trading Transactions of PETER P. PFREUNDSCHUH
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FREQ, IMMU, SCMP, URGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | FREQ | Frequency Therapeu ... | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Jan 19 2021 | FREQ | Frequency Therapeu ... | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 35.85 | 10,000 | 358,500 | 10,000 | |
| Jan 19 2021 | FREQ | Frequency Therapeu ... | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 35.85 | 10,000 | 358,500 | 10,000 | |
| Dec 03 2020 | FREQ | Frequency Therapeu ... | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 27.30 | 230,000 | 6,279,000 | 230,000 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 4,000 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,084 | 0 | 2,082 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 833 | 0 | 1,667 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 21.72 | 1,017 | 22,089 | 10,405 | 11.4 K to 10.4 K (-8.90 %) |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 21.82 | 407 | 8,882 | 11,422 | 11.8 K to 11.4 K (-3.44 %) |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 21.80 | 976 | 21,276 | 11,829 | 12.8 K to 11.8 K (-7.62 %) |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 4,917 | 0 | 12,805 | 7.9 K to 12.8 K (+62.34 %) |
| Sep 01 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 4,166 | |
| Sep 01 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 22.82 | 509 | 11,615 | 7,888 | 8.4 K to 7.9 K (-6.06 %) |
| Sep 01 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 8,397 | 7.4 K to 8.4 K (+14.17 %) |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 417 | 0 | 2,500 | |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 23.51 | 141 | 3,315 | 7,355 | 7.5 K to 7.4 K (-1.88 %) |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 417 | 0 | 7,496 | 7.1 K to 7.5 K (+5.89 %) |
| May 20 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,041 | 0 | 5,208 | |
| May 20 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 25.07 | 358 | 8,975 | 7,079 | 7.4 K to 7.1 K (-4.81 %) |
| May 20 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,041 | 0 | 7,437 | 6.4 K to 7.4 K (+16.28 %) |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 417 | 0 | 2,917 | |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 24.35 | 141 | 3,433 | 6,396 | 6.5 K to 6.4 K (-2.16 %) |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 417 | 0 | 6,537 | 6.1 K to 6.5 K (+6.81 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 6,249 | |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 6,249 | |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 29.68 | 360 | 10,685 | 6,120 | 6.5 K to 6.1 K (-5.56 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 29.68 | 360 | 10,685 | 6,120 | 6.5 K to 6.1 K (-5.56 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 6,480 | 5.4 K to 6.5 K (+19.16 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 6,480 | 5.4 K to 6.5 K (+19.16 %) |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 29.41 | 15,000 | 441,150 | 15,000 | |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,666 | 0 | 3,334 | |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 29.28 | 667 | 19,530 | 4,438 | 5.1 K to 4.4 K (-13.07 %) |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,666 | 0 | 5,105 | 3.4 K to 5.1 K (+48.44 %) |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 7,291 | |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 28.41 | 354 | 10,057 | 3,439 | 3.8 K to 3.4 K (-9.33 %) |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 3,793 | 2.8 K to 3.8 K (+37.88 %) |
| Aug 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 4,167 | 0 | 8,333 | |
| Aug 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 33.07 | 1,416 | 46,827 | 2,751 | 4.2 K to 2.8 K (-33.98 %) |
| Aug 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 4,167 | 0 | 4,167 | 0 to 4.2 K |
| Jan 29 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 29 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 42.50 | 15,000 | 637,500 | 15,000 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Option Exercise | D | 10.90 | 150,000 | 1,635,000 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Sell | D | 18.00 | 263 | 4,734 | 0 | 263 to 0 (-100.00 %) |
| Jan 12 2018 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Grant | A | 9.10 | 263 | 2,393 | 263 | 0 to 263 |
| Jan 12 2018 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Grant | A | 9.10 | 131 | 1,192 | 131 | 0 to 131 |
| Mar 22 2017 | SCMP | Sucampo Pharmaceut ... | PFREUNDSCHUH PETER P. | CFO | Option Exercise | A | 10.90 | 150,000 | 1,635,000 | 150,000 | |
| Aug 24 2015 | IMMU | IMMUNOMEDICS INC | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 1.76 | 38,484 | 67,732 | 38,484 | |
| Aug 24 2015 | IMMU | IMMUNOMEDICS INC | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Grant | A | 0.00 | 15,341 | 0 | 29,706 | 14.4 K to 29.7 K (+106.79 %) |
| Mar 11 2015 | IMMU | IMMUNOMEDICS INC | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 4.01 | 50,000 | 200,500 | 0 | |
| Aug 18 2014 | IMMU | IMMUNOMEDICS INC | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 3.32 | 87,895 | 291,811 | 87,895 | |
| Aug 18 2014 | IMMU | IMMUNOMEDICS INC | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Grant | A | 0.00 | 15,813 | 0 | 15,813 | 0 to 15.8 K |
| Sep 04 2013 | IMMU | IMMUNOMEDICS INC | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 5.85 | 75,000 | 438,750 | 75,000 |
Page: 1